Antimuscarinic Treatment for Female Patients With Overactive Bladder Syndrome: Comparison of Daytime and Nighttime Dosing

N/ACompletedNCT01819168

Far Eastern Memorial Hospital38 enrolled

Overview

The aim of this retrospective study is to analyze if nighttime antimuscarincs may be more effective in treating patients with nocturia.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Overactive Bladder Syndrome

Eligibility

Sex: FEMALEMin age: 20 YearsMax age: 99 Years

Medical Language ↔ Plain English

Inclusion Criteria: * patients who underwent tolterodine SR treatment once per day for 12 weeks in Department of Obstetrics \& Gynecology in National Taiwan University Hospital and Far Eastern Memorial Hospital Exclusion Criteria: \-

Locations (1)

Far Eastern Memorial Hospital

Banqiao District, New Taipei, Taiwan

Outcomes

Primary Outcomes

bladder diary

To clarity any difference of reduction in the episodes of nocturia between these two groups.

Time frame: 3 months

Secondary Outcomes

Frequency and Urgency

To clarity any difference of reduction in the episodes of urinary frequency and urgency between these two groups.

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.